Pricing Log in Create free account

Nanobiotix S.A. - Sponsored ADR (NBTX) vs Intellia Therapeutics, Inc. (NTLA)

Nanobiotix S.A. - Sponsored ADR and Intellia Therapeutics, Inc. are both Biotechnology companies. Nanobiotix S.A. - Sponsored ADR and Intellia Therapeutics, Inc. are of similar size ($1.6B and $1.5B). Nanobiotix S.A. - Sponsored ADR has the higher net margin (0.00% vs −805.8%) and the higher return on invested capital (0.00% vs −195.3%). Across the 15 metrics below, Nanobiotix S.A. - Sponsored ADR leads on 10 and Intellia Therapeutics, Inc. on 5.

Valuation

Metric NBTX NTLA Biotechnology median
P/E n/m n/m 10.60
P/S 6,111.93 29.87 9.40
P/B n/m 2.58 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 5,356.43 20.91 9.02
Earnings yield (10.85%) (29.72%) (32.88%)
Free cash flow yield (13.68%) (22.60%) (23.13%)

Profitability

Metric NBTX NTLA Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% (821.24%) 0.00%
Net margin 0.00% (805.75%) 0.00%
Free cash flow margin 0.00% (671.57%) 0.00%
Return on equity 0.00% (62.60%) (51.96%)
Return on assets 0.00% (46.63%) (46.06%)
Return on invested capital 0.00% (195.32%) 0.00%

Growth

Metric NBTX NTLA Biotechnology median
Revenue growth (TTM) — (8.07%) 6.76%
EPS growth (last fiscal year) 63.46% 27.43% 29.88%
Revenue growth, 5-year CAGR 66.64% 3.13% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NBTX NTLA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.44 6.31 4.97
Net debt to EBITDA 5.66 1.06 1.01

Dividend

Metric NBTX NTLA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NBTX NTLA Biotechnology median
Market cap 1.53b 1.56b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack